The EMA said that the benefits of the AstraZeneca vaccine still outweigh any potential risk of blood clot formation.
Greek health authorities announced on Monday that the benefits of the AstraZeneca vaccine against Covid-19 far outweigh the risks associated with thrombosis.
The EU's ambition of inoculating 70 percent of the population by September is in danger after the reported cases of thrombosis and death.
Doctors believe that early prognosis and diagnosis of conditions linked to thrombosis such as atrial fibrillation and myocardial infarction could save thousands of lives each year. The subject is of much interest to doctors as thrombosis, atrial fibrillation, myocardial infarction and...